Prodia Diagnostic Line Tbk vs Semen Baturaja Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while Semen Baturaja Tbk. trades at Rp166 (market cap 1.67T, 2.93M 24h volume). The key difference: Semen Baturaja Tbk. is far larger — about 3.5× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 2.93M). Which is the better fit depends on your goals.
| PRDL | SMBR | |
|---|---|---|
Market Cap | 470.58B | 1.67T |
Volume | 28.43M | 2.93M |
Lot | 284.34K | 29.25K |
Turnover | 7.8B | 485.3M |
Average Price | 274.19 | 165.91 |
Value | 7.8B | 485.3M |
Indicative Equilibrium Price | 270 | 166 |
Indicative Equilibrium Volume | 2.1K | 23 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Semen Baturaja (Persero) Tbk (the Company) was established by Deed of Notary Jony Frederik Berthold Tumbelaka Sinjai No. 34, in Jakarta, dated November 14, 1974, amended by the same notary on November 21, 1974, amended by the same notary on November 21, 1974 Deed No. 49.
Read more on SMBR →